HBV Forum 2 took place in Amsterdam, the Netherlands and was attended by 55 participants in person and six remotely. Materials and presentations follow.
Materials
Presentations
Welcome and Introductory Remarks
Veronica Miller and William (Bill) Symonds
Hepatitis B Foundation and HBV Forum Meeting with DAVP, FDA
Carol Brosgart and Nathaniel (Nat) Brown
HDV RNA and Anti-HDAg Testing in Europe
Neville-Emmanuel Gordien
Detection Assessment and Management of DILI During Drug Developement for HBV: The IQ-DILI Initiative
Arie Regev
Epitope Mapping the HBsAg to Identify Biomarkers Associated with HBsAg Loss/Seroconversion
Stephen Locarnini
Working Group Updates: Diagnostics and Biomarkers
Ed Marins
Working Group Updates: Treatment Combinations
Bruce Given
Working Group Updates: Surrogate Markers
Oliver Lenz